Role of glucocorticoids in the molecular regulation of muscle wasting.
about
Glucocorticoid receptor signaling in health and diseaseCellular and molecular mechanisms of muscle atrophyGlucocorticoid-induced leucine zipper (GILZ) and long GILZ inhibit myogenic differentiation and mediate anti-myogenic effects of glucocorticoidsEffect of antenatal betamethasone on maternal and fetal amino acid concentration.Dexamethasone and corticosterone induce similar, but not identical, muscle wasting responses in cultured L6 and C2C12 myotubesA genetic predisposition score for muscular endophenotypes predicts the increase in aerobic power after training: the CAREGENE study.Corticosteroids and muscle wasting: role of transcription factors, nuclear cofactors, and hyperacetylationDiet-induced alterations in intestinal and extrahepatic lipid metabolism in liver fatty acid binding protein knockout mice.Muscle wasting associated with pathologic change is a risk factor for the exacerbation of joint swelling in collagen-induced arthritis in cynomolgus monkeysSkeletal, neuromuscular and fitness impairments among children with newly diagnosed acute lymphoblastic leukemiaGlucocorticoids Alter CRTC-CREB Signaling in Muscle Cells: Impact on PGC-1α Expression and Atrophy MarkersAfter the chemotherapy: potential mechanisms for chemotherapy-induced delayed skeletal muscle dysfunction in survivors of acute lymphoblastic leukaemia in childhood.Inspiratory muscle training in a child with nemaline myopathy and organ transplantationEffects of spaceflight on murine skeletal muscle gene expression.MicroRNAs in skeletal muscle: their role and regulation in development, disease and function.Implications of glucocorticoid therapy in idiopathic inflammatory myopathies.Mechanisms of muscle growth and atrophy in mammals and Drosophila.Ligand-based gene expression profiling reveals novel roles of glucocorticoid receptor in cardiac metabolism.Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy.USP19-deubiquitinating enzyme regulates levels of major myofibrillar proteins in L6 muscle cells.Glucocorticoid-mediated repression of REDD1 mRNA expression in rat fetal distal lung epithelial cells.Gene expression changes in subcutaneous adipose tissue due to Cushing's disease.Quantitative analysis of skeletal muscle mass in patients with rheumatic diseases under glucocorticoid therapy--comparison among bioelectrical impedance analysis, computed tomography, and magnetic resonance imaging.Suspected systemic calcinosis and calciphylaxis in 5 horses.Oxidative protein modification alters proteostasis under acute hypobaric hypoxia in skeletal muscles: a comprehensive in vivo study.Relationship between corticosteroid dose and declines in physical function among allogeneic hematopoietic stem cell transplantation patients.mTOR as a Key Regulator in Maintaining Skeletal Muscle Mass.Obestatin controls the ubiquitin-proteasome and autophagy-lysosome systems in glucocorticoid-induced muscle cell atrophy.Cortisone and dexamethasone inhibit myogenesis by modulating the AKT/mTOR signaling pathway in C2C12.Change in muscle volume after steroid therapy in patients with myositis assessed using cross-sectional computed tomography.
P2860
Q26828358-8CB11183-7F20-46D8-B758-294A42A9DA64Q27012762-7DF7BF04-6886-44C0-B45A-7F5FFA551C27Q28509978-4ABA61F2-C325-41F6-83C8-33570E59BF09Q33625146-80EFCC1C-07B5-45D5-94A8-3D544927F87AQ33980095-41D733B1-9C4B-4C1E-876E-77C9FC7AA616Q34038546-E21D7E67-8C4B-46C1-98C7-00030C996EDBQ34115660-0CE5DA33-CCE2-4792-9B65-01FBD2053D37Q34418473-26A55D0A-3633-4547-8630-33C0029B7118Q34802678-5EE44CFD-81F2-4AA2-81F0-2D309FE4C632Q35106981-110C3EE1-13DF-4719-8CDE-D69376C001F7Q36073833-63C82671-1624-4787-82E8-28A0EF48A8A8Q36778333-7F48EFD3-C459-42D1-B922-479EB811D4EAQ36786717-8D05A9E3-F7F1-41E6-BC7B-C1D99852372CQ37101188-81DD1FDA-1212-4576-A147-A136EF1C3808Q37781219-9DA1EA23-9C2A-4B8E-8034-63463167F7B7Q38017953-7A28CF9E-C78F-42C5-8F8D-73C61B7BCD44Q38137908-0EE96592-D7EA-4278-8F56-16A2B894D9E5Q38355808-4546B8CE-D9A6-4928-932A-77A573087C33Q39492090-579CE09A-4CC7-4813-8F38-D49225A26A16Q39796329-CEB3C597-FEE5-4930-8D92-0D1F4A277E6EQ39898105-A8020924-12B9-45F7-8BC8-F59C80EDD1B9Q40762458-AE6B9465-58E6-4490-897E-C1726FAFDFF3Q41703325-67DD7AB7-8877-420C-9721-4C48E0F426A9Q42539656-00F24593-0DC4-4B76-82C5-DDE23E2272C0Q43079012-14A4B6E8-27E2-42CD-8E23-0BDD1F7112C0Q44453411-959AB7A4-3253-4D7C-84E7-203BD9F083FCQ44682872-8B063F86-ABB4-4C22-B2B9-C40ABFB23347Q47137638-66C46FFA-ACE0-4686-BB39-4C06940AE202Q51626949-F8410709-8605-4665-B860-36059145D759Q54958272-9E598347-FE38-4247-A97C-6621E89272C3
P2860
Role of glucocorticoids in the molecular regulation of muscle wasting.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Role of glucocorticoids in the molecular regulation of muscle wasting.
@en
type
label
Role of glucocorticoids in the molecular regulation of muscle wasting.
@en
prefLabel
Role of glucocorticoids in the molecular regulation of muscle wasting.
@en
P2093
P1476
Role of glucocorticoids in the molecular regulation of muscle wasting.
@en
P2093
Michael Menconi
Moin Fareed
Patrick O'Neal
Per-Olof Hasselgren
Vitaliy Poylin
P304
P356
10.1097/01.CCM.0000279194.11328.77
P407
P433
P577
2007-09-01T00:00:00Z